For patients receiving long-term hemodialysis, central venous occlusion (CVO) represents a severe and troublesome vascular access complication. Once central venous flow is blocked, normal hemodialysis access cannot function as designed. Patients commonly suffer from refractory limb swelling, persistent pain, and impaired venous return, which drastically reduce treatment tolerance and overall quality of life. Conventional endovascular intervention has long been the mainstream strategy for CVO management. However, a subset of patients present with difficult, dense occlusive lesions that standard wires and catheters cannot cross. Repeated blind wire probing raises risks of vascular dissection, perforation, and procedural failure. In these challenging cases where traditional endovascular approaches fail, Chiba needle-assisted recanalization offers a viable minimally invasive solution. This article reviews the clinical outcomes, procedural workflow, safety profile, and practical insights of Chiba needle recanalization combined with angioplasty and stenting for hemodialysis-related CVO.

Clinical Pain Points of Difficult Central Venous Occlusion in Hemodialysis

Hemodialysis patients are at uniquely high risk of developing central venous occlusion. Repeated vascular cannulation, chronic indwelling venous catheters, endothelial injury, and altered hemodynamics collectively trigger intimal hyperplasia, fibrosis, and eventual complete luminal obliteration. For vascular access specialists, CVO is a recurring clinical dilemma. Standard endovascular tactics including balloon angioplasty and stent placement work well for most partial or soft stenotic lesions. Fully occluded, fibrotic CVO segments are far more difficult to negotiate.

When operators cannot advance a guidewire through the true lumen despite multiple attempts, the case is classified as difficult CVO. Prolonged fluoroscopy time increases radiation exposure for both patients and operators. Multiple blind passes may create false lumens, making subsequent intervention even harder. Failed endovascular recanalization forces clinicians to consider more invasive open surgical reconstruction or alternative access creation, which carries higher surgical morbidity and longer recovery time. There is a clear clinical demand for a controlled, sharp recanalization technique that can traverse dense fibrotic occlusions while keeping major complications at an acceptable level. Chiba needle-assisted sharp recanalization has emerged to fill this therapeutic gap.

Technical Principles and Standard Procedural Steps of Chiba Needle Recanalization

The Chiba needle is a thin, sharp-tipped puncture instrument with a slanted bevel design. Under fluoroscopic guidance, its small profile allows controlled sharp penetration through dense fibrotic occlusive tissue. The core objective is to create a safe initial channel through the occlusion, which then enables guidewire passage, balloon dilation, and stent deployment. All procedures follow a predefined standardized protocol.

First, a vascular sheath is advanced as close as possible to the proximal edge of the occlusive segment. Diagnostic venography is performed to confirm the exact location and length of the occlusion. A balloon or snare device is often placed distal to the occlusion as a target marker to improve puncture accuracy. This landmark helps the operator aim toward the true lumen and reduces off-target puncture.

A manually angled 21 G to 22 G Chiba needle (Cook) is delivered through the vascular sheath under continuous fluoroscopy. Operators intentionally center the needle trajectory within the expected vascular lumen to minimize the risk of extravascular perforation. The needle is advanced carefully across the occlusive segment. Once the needle tip passes through the occlusion, a 0.018-inch guidewire is introduced through the lumen of the Chiba needle.

Technical success is confirmed when venography shows restored flow without contrast extravasation. If residual stenosis greater than 30%, sluggish flow, or visible contrast leakage is identified, stent implantation is performed after balloon angioplasty. A critical safety adjustment in this protocol is delayed heparin administration. Heparin is withheld until the operator verifies no active vascular bleeding, which lowers bleeding-related adverse events. Emergency surgical backup must be available for all cases given the inherent risk of vascular injury during sharp recanalization.

Clinical Outcomes from the Retrospective Study

This retrospective analysis extracted data from a prospectively maintained database of hemodialysis patients treated with Chiba needle recanalization for CVO. All enrolled patients received scheduled clinical follow-up at 3 months, 6 months, and 12 months. Primary endpoints were technical success rate and primary patency rate. Secondary endpoints included complication rate and clinical success rate.

A total of 40 patients were included in this study. Technical and clinical success was achieved in 36 patients, corresponding to a 90% success rate. Immediate post-procedural complications occurred in 17.5% of the cohort. Minor complications were recorded in 10% of patients. Major complications appeared in 7.5% of patients, including two cases of hemothorax and one case of pneumothorax.

At the one-year follow-up, reintervention was required in 22.5% of patients. The primary patency rate reached 77.5%, and secondary patency was 100%. These results demonstrate that Chiba needle sharp recanalization delivers reliable technical success, acceptable major complication risk, and durable secondary patency for difficult CVO that cannot be crossed by conventional wires. Although a proportion of patients need repeat intervention to maintain access, the technique avoids permanent access abandonment for most individuals.

Practical Operative Tips for Safe Chiba Needle Recanalization

Operator experience and strict attention to detail strongly influence safety outcomes. Centering the Chiba needle trajectory along the longitudinal axis of the target vein is the single most important maneuver to prevent perforation. Using a distal balloon or snare as a fluoroscopic target substantially improves directional control, especially for long, tortuous, or poorly visualized occlusive segments.

The modified anticoagulation strategy is specific to sharp recanalization cases. Early systemic heparinization raises bleeding risk if the needle inadvertently penetrates outside the vessel wall. Delaying heparin until extravasation is excluded is a simple but effective risk-reduction measure. The team must maintain emergency preparedness for thoracic bleeding and pneumothorax, as these are the most feared major adverse events.

Patient selection is another key consideration. Chiba needle recanalization is reserved for patients with complete CVO where standard wire traversal has failed. It is not a first-line technique for easily crossed stenoses or soft partial occlusions. After successful recanalization, long-term surveillance is essential. CVO has a high tendency for restenosis. Regular clinical and imaging follow-up allows timely reintervention before access thrombosis occurs.

Conclusion and Clinical Value for Hemodialysis Vascular Access

When conventional endovascular intervention fails to traverse hemodialysis-related central venous occlusion, Chiba needle recanalization combined with angioplasty and stenting provides a valuable rescue strategy. It achieves promising technical success, measurable clinical improvement, and favorable primary patency with a manageable major complication profile. The 90% technical success rate and 100% secondary patency at one year support its role as a salvage minimally invasive option for difficult CVO.

Even so, this sharp recanalization technique carries a notable learning curve. Operators need robust fluoroscopic interpretation skills, clear understanding of mediastinal and central venous anatomy, and consistent hands-on training to reduce perforation risk. With the rising prevalence of long-term hemodialysis worldwide, difficult CVO will remain a common access challenge. The Chiba needle will continue to serve as an indispensable tool in the interventional armamentarium for vascular access specialists, helping preserve central venous access and avoiding the need for more invasive open surgery. For selected high-risk patients, this technique balances therapeutic benefit and procedural risk, representing an important advance in hemodialysis vascular access care.